Abstract-Intra-arterial infusion of insulin in physiological doses causes forearm vasodilation which is augmented by co-infusion of D-glucose, leading us to speculate that local insulin-mediated vasodilation may depend on insulinmediated glucose uptake. We have examined the relationship between whole-body insulin sensitivity and forearm vasodilation in response to local infusion of insulin/glucose, thus avoiding any confounding effects of sympathetic stimulation on peripheral blood flow. Eighteen healthy, normotensive male volunteers (age, 26Ϯ5.4 years) attended on two separate occasions for measurement of: (1) whole-body insulin sensitivity with use of the hyperinsulinemic euglycemic clamp; (2) forearm vasodilation in response to an intra-arterial infusion of insulin/glucose with use of bilateral venous occlusion plethysmography. Insulin-mediated glucose uptake (M) for the group (meanϮSD) was 10.0Ϯ2.2 mg ⅐ kg Ϫ1 ⅐ min
insulin and regulation of blood flow have been less clear; although some studies have demonstrated a relationship between insulin resistance and endothelial dysfunction, 18, 19 others have not. 20 In addition, there is considerable doubt concerning whether insulin sensitivity and insulin-mediated vasodilation are functionally associated. 20 -22 Those studies that have shown a relationship 23, 24 have used higher doses of insulin and the results are thus of questionable physiological significance.
We hypothesized that the discrepancy between in vitro and in vivo data on the relevance of insulin-mediated vasodilation to insulin-mediated glucose uptake might be attributable to the confounding effect of sympathetic nervous system activation during systemic hyperinsulinemia. 25, 26 In this setting, local vasodilator effects are likely to be influenced by centrally mediated mechanisms. Although these effects are physiologically relevant, we chose to examine forearm responses to local intrabrachial insulin infusions to focus on local actions of the hormone. Until recently, local insulin infusions were thought to have either no effect on limb blood flow [27] [28] [29] or only a very weak influence. 30, 31 However, we have demonstrated in humans that forearm vasodilation during local physiological insulin infusions is significantly augmented by co-infusion of intra-arterial D-glucose. 32 This was not simply an osmotic effect because co-infusing L-glucose had no effect. 32 This result led us to hypothesize that insulin-stimulated tissue glucose uptake is a determinant of insulin-mediated vasodilation. In the present study, we set out to examine the relationship at physiological insulin concentrations between local insulin/glucose forearm vasodilation and whole-body glucose uptake during systemic hyperinsulinemia.
Methods

Subjects
Eighteen healthy, normotensive male volunteers aged 18 to 37 years participated in this study, which was approved by the Ethics Committee of the West Glasgow Hospitals University NHS Trust. All subjects gave informed consent, and the procedures followed were in accordance with Ethics Committee guidelines. No subjects were taking medication, and all abstained from alcohol, tobacco, and strenuous physical activity for 24 hours and from food and caffeinecontaining drinks overnight before the 2 study days, which were at least 1 week apart. At a screening visit, physical health was confirmed by history and physical examination and supine blood pressure was measured in triplicate (Dinamap Critikon, Johnson and Johnson Professional Products Ltd). Subject characteristics included age 26Ϯ5. 4 
Clinical Procedures Measurement of Insulin Sensitivity
Subjects attended for measurement of whole-body insulin sensitivity (M) by use of a 180-minute hyperinsulinemic euglycemic clamp. 33 A primed continuous infusion of soluble insulin (10.8 pmol ⅐ kg Ϫ1 ⅐ min
Ϫ1
; Novo-Nordisk UK) was administered along with a variable rate infusion of 20% dextrose (Baxter Health Care) adjusted manually to maintain serum glucose at 5.2 mmol/L on the basis of arterialized samples withdrawn every 5 minutes from an ipsilateral right dorsal hand vein (heated-air box at 55°C, University of Nottingham Department of Physiology and Pharmacology). The M-value was calculated during the last 40 minutes of the study. 33 
Measurement of Insulin-Mediated Vasodilation
Forearm blood flow was measured by venous occlusion plethysmography with electrically calibrated mercury-in-silicone elastomer (Silastic) strain gauges (Hokanson set, PMS instruments). 34 A 27-gauge unmounted steel needle (Cooper's Needleworks) was inserted under local anesthesia into the brachial artery of the nondominant arm for infusions. A venous catheter was positioned retrogradely in an antecubital vein to enable half-hourly blood sampling for insulin, glucose, and potassium levels. Temperature was maintained at 24 to 26°C. Blood flow was recorded in both forearms during 3-minute periods of wrist cuff inflation at 10-minute intervals; each measurement was the mean of 5 sequential recordings.
After baseline readings had been obtained, subjects received an intra-arterial infusion of low-dose D-glucose (75 mol/min) for 120 minutes to maintain local venous euglycemia in the forearm vascular bed. After 30 minutes, and for the remaining 90 minutes, soluble human insulin (Actrapid, Novo Nordisk) was co-infused at a dose of 36 pmol/min. This solution was prepared in the sterile unit of the hospital pharmacy with use of glass syringes and bottles, and diluted (with saline and 4 mL of the subject's blood, 8% vol/vol) at the bedside immediately before each study (mean recovery of insulin was 95%; data not shown). In a previous study, we demonstrated that deep venous glucose levels in the contralateral arm were unchanged by this dose of insulin, confirming that there is unlikely to be any significant systemic action of insulin. 32 A uniform infusion rate (2 mL/min) was used throughout the study.
Statistical Evaluation
For the forearm plethysmography data, percentage change from basal values in the ratio of blood flow between infused and noninfused arms was calculated, with the blood flow in the noninfused arm as a concurrent control. 34 To avoid multiple comparisons, a summary measure was calculated which was the mean value of the last 3 readings (100 to 120 minutes). 35 Data were initially examined by simple correlation. If data were nonparametrically distributed, the rank correlation coefficient was calculated. Multiple regression analysis (Minitab for Windows, Minitab Inc.) was performed to examine potential confounders. Insulin sensitivity, age, and MAP data were normally distributed; insulin vasodilation and BMI data were nonparametrically distributed and were therefore logarithmically transformed before analysis. After identification of the best subsets in the initial model, parameters were added in a forward stepwise fashion.
Results
The procedures were performed without complication and were well tolerated by all subjects. During plethysmography, deep venous potassium concentration was not significantly different from baseline in response to intra-arterial infusion of insulin and glucose.
Insulin Concentrations
During the euglycemic clamps, systemic insulin concentrations were raised to 617Ϯ99.7 pmol/L during the last hour. During the local insulin infusions, insulin levels in the forearm vascular bed were raised to 782Ϯ279.8 pmol/L during the last hour.
Whole-Body Insulin Sensitivity
M-value (meanϮSD) for the group was 10.0Ϯ2.2 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 (range, 6.8 to 14.7).
Local Insulin/Glucose-Mediated Vasodilation
Percentage change in forearm blood flow ratio (%FBFR) for the group (median, interquartile range) was 28.2% (13.6, 48.6).
Univariate Analysis
Depending on the distribution of the data, simple (r) or rank correlation (r s ) analysis was performed. 
Multiple Regression Analysis
The 
Discussion
This study is the first to examine the relationship between whole-body insulin sensitivity and insulin-mediated vasodi-lation with use of a physiological model in the absence of potentially confounding hemodynamic variables such as stimulation of the sympathetic nervous system. We report that vasodilation induced by local intra-arterial infusion of insulin/glucose is independently associated with whole-body insulin-mediated glucose uptake in healthy male volunteers. Clearly, we acknowledge that, in vivo, insulin is secreted from the portal into the systemic circulation and, therefore, sympathetic stimulation is a physiological event that may influence peripheral blood flow. However, the purpose of this study was to negate sympathetic influences to examine the presence or absence of a significant functional relationship between insulin's metabolic and vascular actions, which has been the subject of much controversy. 20 -23,36,43,44 Baron et al 23 have previously demonstrated a significant relationship between whole-body insulin sensitivity and leg vasodilation during systemic hyperinsulinemia in healthy subjects. However, Yki-Jarvinen et al, 21 although conceding that endothelial function is a significant determinant of insulin-mediated vasodilation, were unable to demonstrate a relationship between insulin sensitivity and forearm vasodilation in response to systemic hyperinsulinemia. 20, 21 In support of this conclusion, this group used positron emission tomography (PET) and [ 18 F]fluoro-2-deoxy-D-glucose uptake to demonstrate a dissociation of insulin-stimulated blood flow and glucose uptake in thigh skeletal muscle. Despite this finding, however, the same study demonstrated a significant relationship between insulin-induced leg vasodilation and whole-body insulin sensitivity during systemic hyperinsulinemia, 22 and the overall conclusion from these studies remains uncertain. In a more recent study in which higher resolution methods were used, the same group was able to detect co-localization of insulin-stimulated muscle blood flow with regional glucose uptake, consistent with redirection of flow to areas where insulin stimulates glucose uptake. 36 Our data, which demonstrate a close correlation between direct insulin/ glucose-induced arterial vasodilation and whole-body insulin-stimulated glucose uptake, also support this hypothesis.
We have observed that local insulin-mediated vasodilation is significantly augmented by co-infusion of D-glucose and have hypothesized that insulin-stimulated glucose uptake may determine muscle blood flow via crosstalk with nitric oxide pathways at an endothelial level. For example, an increase in ATP production caused by aerobic glycolysis could activate membrane ion pumps (for example Na ϩ -K ϩ ATPase) resulting in hyperpolarization and changes in Ca 2ϩ fluxes in both endothelium and vascular smooth muscle cells. 37 In support of this notion we, and others, have recently shown that insulin-mediated vasodilation can be inhibited by ouabain, an inhibitor of Na ϩ -K ϩ ATPase. 38, 39 Furthermore, clamping glucose at 20 mmol/L during systemic hyperinsulinemia (and hence increasing tissue glucose uptake) causes 50% augmentation of insulin-stimulated blood flow in humans. 40 Several in vitro studies provide additional evidence that glucose uptake may be important in determining vascular smooth muscle cell relaxation. 13, 14, 41 Of particular note is a study demonstrating nitric oxide production secondary to insulin stimulation in endothelial cell culture and subsequent blocking of this in the presence of an inhibitor of phosphatidyl inositol 3-kinase. 15 The delayed time course of insulinmediated vasodilation would also support this hypothesis: the vasodilator effect of the hormone is only evident after 30 to 40 minutes, consistent with primary effects to increase glucose uptake and metabolism. One pathophysiological implication of this hypothesis would be that a primary derangement of insulin-mediated glucose uptake would lead to reduced insulin-mediated vasodilation (and, possibly, effects on other aspects of vascular endothelial function), so providing a mechanism for vascular dysfunction in insulinresistant subjects. The absence of a change in blood flow Insulin sensitivity (M: mg ⅐ kg Ϫ1 ⅐ min Ϫ1 ) in 18 healthy male volunteers plotted against percent change in forearm blood flow ratio in response to a 90-minute intra-arterial infusion of insulin and glucose. during a systemic infusion of fructose 42 could be cited as an argument against this hypothesis, but does not rule out the possibility that the coupling signal for promotion of blood flow is unique to intracellular glucose metabolism.
Multiple Regression Models With Insulin Sensitivity (M) as Dependent Variable
The alternative physiological hypothesis, originally advanced by Baron, is that insulin-mediated vasodilation promotes insulin-mediated glucose uptake. This has the pathophysiological corollary that endothelial dysfunction, resulting in a relative inability of mediators including insulin to stimulate muscle blood flow, could account for resistance to insulin-mediated glucose uptake in some disorders. 43 However, this hypothesis assumes that substrate delivery can be rate-limiting for glucose disposal, which may only be the case at supraphysiological insulin levels maintained for many hours. Results of studies in which glucose uptake has been measured during hyperinsulinemia and manipulation of limb blood flow are conflicting. For example, it has been reported that infusion of N G -monomethyl-L-arginine (L-NMMA) into the femoral artery during hyperinsulinemic euglycemia reduces insulin-mediated stimulation of blood flow (via inhibition of endothelial nitric oxide production) and decreases limb glucose uptake by 25% (despite a 50% increase in arteriovenous fractional glucose extraction). 23 However, other investigations have failed to support the notion that tissue glucose uptake is dependent on skeletal muscle blood flow. 44 -46 Dissociation of insulin-mediated glucose uptake from blood flow was observed in a study in which both limb blood flow and muscle sympathetic nerve activity were stimulated to similar degrees at different systemic insulin concentrations, ranging from 100 to 400 pmol/L. 25 In addition, augmentation of forearm blood flow by 100% with use of intra-arterial adenosine 47 and bradykinin 48 has no detectable effect on forearm glucose uptake. However, it has been argued that these vasodilators (in contrast to insulin) may not recruit areas of tissue that were previously involved in predominantly anaerobic metabolism. 24 Because correlation is not proof of causality, the possibility remains that insulin's metabolic and vascular actions are not causally related in either direction but are influenced by a third factor. For example, obesity could impair insulinmediated glucose uptake and vascular endothelial function by two separate mechanisms. It has been shown that obese insulin-resistant subjects are characterized by endothelial dysfunction and resistance to endothelium-dependent insulinmediated vasodilation, and that there is no difference in these variables in a group of patients with NIDDM, matched for age and BMI. 19 These results suggest that obesity may play a primary role in the link between insulin resistance and endothelial dysfunction, and it may help to explain why results obtained in obese NIDDM and hypertensive patient groups cannot necessarily be extrapolated to patients with a normal BMI. However, the relationship between insulinmediated vasodilation and glucose uptake was not confounded by BMI in the current study.
In summary, we report in healthy male volunteers a significant functional relationship between insulin sensitivity and local insulin-mediated vasodilation in an experimental setting that avoids the confounding hemodynamic effects of systemic hyperinsulinemia. Further mechanistic studies are required to tease out the nature of the crosstalk between insulin signaling, glucose transport, and the endothelial nitric oxide pathway. These studies may elucidate the relationship between insulin resistance and endothelial dysfunction in the early stages of cardiovascular and metabolic disorders before the development of complications.
